Research
on China Monoclonal Antibody (McAB) Industry, 2014 mainly carries on in-depth
analysis on policy environment, global market, Chinese market, as well as the
latest developments of domestic key enterprises related to China's monoclonal
antibody industry.
Several
Chinese large-scale pharmaceutical enterprises devoted themselves to research
and development of monoclonal antibody agents, which have achieved results in
2013. Hengrui Medicine Co., Ltd., Shanghai Pharmaceuticals Co., Ltd. and Qilu
Pharm have applied for clinical research of monoclonal antibody agents. And
Walvax Biotechnology Co., Ltd even made a huge investment in purchasing Genor
Biopharma Co., Ltd, attempting to establish a large biological strategy.
Browse
Full Report With TOC @ http://www.radiantinsights.com/research/research-on-china-monoclonal-antibody-mcab-industry-2014
Although
large-scale pharmaceutical enterprises entered monoclonal antibody field on a
large scale, the overall innovation is still insufficient, and the market is
represented by monoclonal antibody agents and biological analogue that have
submitted applications, few imitated drugs, and innovative medicines are rare
and precious things, mainly on account of high risks and long-time cycle.
Due to
late state, China's strength on research and development will be still
vulnerable within future three to five years, so it has to open the market
preliminarily by depending on generic drugs. In 2013, the market size was CNY
3.8 billion around, up 30% year-on-year; product categories and sales volume
were far less than that of European and American countries.
According
to statistical data of Shanghai Pharmaceutical Profession Association (SPPA), China
will see four to six monoclonal antibody agents by 2016, such as Trastuzumab
and Rituximab. And it is expected by 2020, six to ten monoclonal antibody
agents will be listed in market, and some of which are independently researched
drugs. Huidian Research believes that China's monoclonal antibody market will
embrace its first climax from 2017 to 2020.
About Us
Radiant Insights is a platform for companies looking to meet their
market research and business intelligence requirements. We assist and
facilitate organizations and individuals procure market research reports,
helping them in the decision making process. We have a comprehensive collection
of reports, covering over 40 key industries and a host of micro markets. In
addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For more information visit: Radiant
Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
No comments:
Post a Comment